Диссертация (1139499), страница 47
Текст из файла (страница 47)
– Vol.282. – P.2035-2042.394. Malik M. Heart rate variability./ Malik M., Camm A.// Armonk, N.-Y. - FuturaPablishing Co. - 1995. - P. 369 – 392.395. Malyusz M. Effect of castration on the experimental renal hypertension of therat./ Malyusz M, Ehrens H-J, Wrigge P.// Nephron. – 1985. – Vol.40.
– P.96-99.396. Mancia G. 2007 Guidelines for the Management of Arterial Hypertension. TheTask Force for the Management of Arterial Hypertension of the European Society ofHypertension (ESH) and of the European Society of Cardiology (ESC)/ Mancia G. [etal]// J Hypertens. – 2007. – Vol.25. – P.1105–1187397. Mankhey R. 17-beta estradiol supplementation reduces tubulointerstitial fibrosisby increasing MMP activity in the diabetic kidney./ Mankhey R.
[et al]// Am J PhysiolReg Integr Comp Physiol. – 2006. – Vol.292. – P.R769–R777.398. Mann S.L. Elevation of ambulatory systolic blood pressure in hypertensivesmokers: a case-control study/ Mann S.L. [et al] // JAMA. – 1991. – Vol. 265. – P.2226-2228.399. Martin RM. Age and sex distribution of suspected adverse drug reactions tonewly marketed drugs in general practice in England: analysis of 48 cohort studies./Martin RM.
[et al]// Br J Clin Pharmacol. – 1998. – Vol.46. – P.505–511.400. Martinez-Lemus LA. The plastic nature of the vascular wall: a continuum ofremodeling events contributing to control of arteriolar diameter and structure./Martinez-Lemus LA, Hill MA, Meininger GA. // Physiology. – 2009. – Vol.24. – P.4557.401. Masiha S. Left ventricular geometric patterns and adaptations to hemodynamicsare similar in elderly men and women./ Masiha S., Sundström J. and Lind L.// BMCCardiovasc Disorders. – 2011. – Vol.11. – P.25 .293402.
Masuda A. Testosterone increases thromboxane A2 receptors in cultured rataortic smooth muscle cells./ Masuda A, Mathur R, Halushka PV. // Circ Res. -1991. Vol.69. – P.638–643.403. Matthews KA. Changes in cardiovascular risk factors by hysterectomy status withand without oophorectomy./ Matthews KA.
[et al]// J Am Coll Cardiol. – 2013. - Vol.62. - No. 3. - P.191-200.404. McCeady R. Does homocysteine contribute to menopausal vascular disease risk?/McCeady R [et al]// Eur Rev Med Pharmacol Sci. – 2002. – Vol.6(4). – P.87-91.405. McCullough PA. CKD and cardiovascular disease in screened high-risk volunteerand general populations: the Kidney Early Evaluation Program (KEEP) and NationalHealth and Nutrition Examination Survey (NHANES) 1999-2004./ McCullough PA [etal]// Am J Kidney Dis. – 2008. – Vol.51(4 Suppl. 2).
– P.S38-S45.406. McGuire BB. Gender differences in the renin-angiotensin and nitric oxidesystems: relevance in the normal and diseased kidney./ McGuire BB [et al]// KidneyBlood Press Res. – 2007. – Vol.30. – P.67–80.407. Meadows JL. Endothelial biology in the post-menopausal obese woman./Meadows JL., Vaughan DE. // Maturitas. – 2011. – Vol.69. - P.120–125.408. Melo RM. Training-induced, pressure-lowering effect in SHR: wide effects oncirculatory profile of exercised and nonexercised muscles./ Melo RM, Martinho E Jr,Michelini LC.
// Hypertension. – 2003. – Vol.42. – P.851-857.409. Mercuro G. Effect of acute administration of transdermal estrogen onpostmenopausal women with systemic hypertension./ Mercuro G. [et al]// Am J Cardiol.– 1997. – Vol.80. – P.652-655.410. Mercuro G. Gender determinants of cardiovascular risk factors and diseases./Mercuro G [et al]// J Cardiovasc Med (Hagerstown). – 2010. – Vol.11(3). – P.207-20.411. Messerli F.
Dimorphic cardiac adaptation to obesity and arterial hypertension./Messerli FH [et al]// Ann Intern Med. – 1983. – Vol.99. – P.757-61.412. Messerli FH. Disparate cardiovascular findings in men and women with essentialhypertension./ Messerli FH [et al]// Ann Intern Med.
– 1987. – Vol.107. – P.158-161.294413. Miller AA. Effect of gender on NADPH-oxidase activity, expression, andfunction in the cerebral circulation: role of estrogen./ Miller AA [et al]// Stroke. – 2007.– Vol.38. – P.2142-9.414. Miller V.M. Cardiovascular disease risk factors and menopausal status in midlifewomen from the former Soviet Union./ Miller V.M. [et al]// Women Health. – 2003.
–Vol.38. – P.19-36.415. Miller VM. Vascular actions of estrogens: functional implications./ Miller VM,Duckles SP. // Pharmacol Rev. – 2008. – Vol.60. – P.210–41416. Mogil JS. Sex differences in the antagonism of swim stress-induced analgesia:effects of gonadectomy and estrogen replacement./ Mogil JS. [et al]// Pain. – 1993. Vol.53. - № 1. - P.17–25.417. Moreno C. Genomic map of cardiovascular phenotypes of hypertension in femaleDahl S rats./ Moreno C.
[et al]// Physiol Genomics. – 2003. – Vol.15. – P.243-257.418. Moriel P. Nitric oxide, cholesterol oxides and endothelium-dependentvasodilation in plasma of patients with essential hypertension./ Moriel P. [et al]// Braz JMed Biol Res. – 2002. – Vol.35(11).
– P.1301-9.419. Morse SA. Hypertension and metabolic syndrome./ Morse SA. [et al]// Am J NedSci. – 2005. – Vol.330. – P.303-310.420. Mosca L. Effectiveness-Based Guidelines for the Prevention of CardiovascularDisease in Women− 2011 Update: A Guideline From the American Heart Association/Mosca L [et al]// Circulation. – 2011. – Vol.123. – P.1243-62.421. Mosca L. Evidence-based guidelines for cardiovascular disease prevention inwomen./ Mosca L [et al]// Circulation. – 2004.
– Vol.109. – P.672-93.422.Mosca L. Fifteen-Year Trends in Awareness of Heart Disease in Women Resultsof a 2012 American Heart Association National Survey./ Mosca L. [et al]// Circulation.– 2013. – Vol.27(11). – P.1254-63, e1-29.423. Mucha L. Meta-analysis of disease risk associated with smoking, by gender andintensity of smoking./ Mucha L [et al]// Gend Med. – 2006. – Vol.3. – P.279-291.295424. Muiesan ML.
Sex differences in hypertension-related renal and cardiovasculardiseases in Italy: the I-DEMAND study./ Muiesan ML [et al]//J Hypertens. – 2012. –Vol.30(12). – P.2378-86.425. Muller M. Endogenous sex hormones in men aged 40-80 years/ Muller M. [et al// Eur J Endocrinol. – 2003 - Vol.149. – Issue 6. – P.583-589.426. Mundal R. Predictors of 7-year changes in exercise blood pressure: effect ofsmoking? Physical fitness and pulmonary function/ Mundal R. [et al] // J Hypertens. –1997. – Vol.
15. – P. 245-249.427. Mussalo H. Heart rate variability and its determinants in patients with severe ormild essential hypertension/Mussalo H [et al] // Clin Physiol. - 2001. – Vol.21(5). –P.594-604.428. MсNeill AM. The Metabolic Syndrome and 11-Year Risk of IncidentCardiovascular Disease in the Atherosclerosis Risk in Communities Study./ MсNeillAM [et al]// Diabetes Care.
– 2005. – Vol.28. - №2. - P.385-90.429. Narkiewicz K. An independent relationship between plasma leptin and heart ratein untreated patients with essential hypertension./ Narkiewicz K. [et al]// JHypertension. – 1999. – Vol.17. – P.245-249.430. Neaton JD. Serum cholesterol, blood pressure, cigarette smoking, and death fromcoronary heart disease. Overall findings and differences by age for 316,099 white men.Multiple Risk Factor Intervention Trial Research Group./ Neaton JD, Wentworth D.//Arch Intern Med. – 1992. – Vol.152(1).
– P.56-64.431. Nejatizadeh A. Endothelial nitric oxide synthase gene haplotypes and circulatingnitric oxide levels significantly associate with risk of Essential hypertension /Nejatizadeh A. [et al] // Free Radical Biology and Medicine.-2008.- Vol.44.- Р.1912–1918432. Neugarten J. Glomerulosclerosis in aging humans is not influenced by gender./Neugarten J.
[et al]// Am J Kidney Dis. – 1999. – Vol.34. – P.884–888.433. Neugarten J. Selective estrogen receptor modulators suppress mesangial cellcollagen synthesis./ Neugarten J. [et al]// Am J Physiol Renal Physiol. – 2000. –Vol.279. – P.F309-18.296434. Ng VA. Age and gender influence muscle sympathetic nerve activity at rest inhealthy humans./ Ng V.A. [et al]// Hypertension. – 1993.
– Vol.21. – P.498–503.435. Nichols M. European Cardiovascular Disease Statistics 4 th edition, 2012. /Nichols M [et al]// EuroHeart II. Eur Heart J. – 2013. – Vol.34. – P.3007.436. Noto R. Hyperhomocysteinemia in menopausal hypertension: an added risk factorand a dangerous association for organ damage./ Noto R [et al]// Eur Rev MedPharmacol Sci. – 2002. – Vol.6(4). – P.81-7.437. Nurk E. Changes in lifestyle and plasma total homocysteine: the HordalandHomocysteine Study./ Nurk E [et al]// Am J Clin Nutr. – 2004. – Vol.79(5).
– P.812-9.438. Oak JH. Attenuation of Angiotensin II Signaling Recouples eNOS and InhibitsNonendothelial NOX Activity in Diabetic/ Oak JH, Cai H. //Diabetes. – 2007. –Vol.56(1). – P.118-26.439. Ogbemudia EJ. Association between gender and left ventricular geometry inhypertension./ Ogbemudia EJ, Iruolagbe CO. // Nigerian J Cardiol. – 2013. – Vol.10(1).- P.22-25.440.
Ojeda NB. Sex differences in the developmental programming of hypertension./Ojeda NB, Intapad S, Alexander BT. // Acta Physiol (Oxf). – 2014. – Vol.210(2). –P.307-16.441. OrentreichN.Long-termlongitudinalmeasurementsofplasmadehydroepiandrosterone sulfate in normal men./ Orentreich N. [et al]// J Clin EndocrinolMetab. – 1992. - Vol.75. – P.1002-4.442. Orshal JM. Gender, sex hormones, and vascular tone./ Orshal JM, Khalil RA, //Am J Physiol Regul Integr Comp Physiol. – 2004. – Vol.286. – P.R233-49.443. Orth S.R. Smoking as a risk factor for end – stage renal failure in men withprimary renal disease./ Orth SR. [et al]//Kidney Int.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
